Blake Smith
Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1770979221
Payments from drug & device makers
What this record shows
This record is dominated by grants: $22,000 of the $35,656 with a category attached, or 61.7%. 11 manufacturers reported payments, led by Medtronic at 34.4% of the total. Reporting peaked in 2022 at $20,708 and has fallen 99.1% since, to $193 in 2025.
Across 73 payments — averaging $488.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Boston Scientific$11K
- Ablacon, Inc.$8K
- Biotronik Inc.$3K
- Abbott$927
- Biosense Webster, Inc.$201
- plus $341 from 5 others
What the payments were for
- Consulting fees$6,00017%
- Grants$22,00062%
- Travel & lodging$3,0499%
- Food & beverage$4,19412%
- Education$4121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $12,269 |
| Boston Scientific | 16 | $10,964 |
| Ablacon, Inc. | 4 | $7,555 |
| Biotronik Inc. | 23 | $3,398 |
| Abbott | 15 | $927 |
| Biosense Webster, Inc. | 2 | $201 |
| Nobel Biocare USA | 3 | $146 |
| Altathera Pharmaceuticals LLC | 1 | $126 |
| Sanofi | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$5,000
- S-ICD System Magnet$5,000
- ENSITE PRECISION$297
- Carto 3$196
- BioMonitor$146
- Rivacor$146
- Solia$146
- Edora$146
- Acticor$146
- EMBLEM MRI S-ICD$143
- AMPLATZER$140
- Sotalol Hydrochloride$126
- AFFERA MAPPING SYSTEM$121
How this compares
$35,656 in reported general payments places this provider in the 60th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $80,267 |
| Flecainide Acetate | 22 | $1,168 |
| Metoprolol Succinate | 42 | $1,148 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $519 |
| Amiodarone Hcl | 11 | $267 |
| Metoprolol Tartrate | 15 | $49 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Birmingham
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
- Byron ColleyBirmingham$59K
- Macy SmithBirmingham$45K
- Chad ColonBirmingham$42K
- Ahmad JalladBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.